When debt goes unpaid for too long, even banks and major financial institutions need to get some help on board.…
In 2023, cancer is responsible for about three in 10 deaths across Australia. And among women, breast cancer remains the…
After ousting Anthony Nantes as CEO in August 2023 (and subsequently seeing John Nantes depart as Chairman), consumer lending company…
After gaining US FDA approval in September 2023, nuclear medicine company Cyclopharm (ASX: CYC) has made an official entry into…
Precision microbiome company Microba (ASX: MAP) and the US-based F&B company International Flavors & Fragrances (IFF) have entered the second…
After becoming a member of the US CLAWS hub in October 2023, semiconductor developer BluGlass (ASX: BLG) has signed its…